GSK

CEF Lead Executives

Latest Sustainability Reporting

Highlights


  • In 2025, reduced Scope 1 and 2 emissions by 45% and reduced Scope 3 emissions 16% (2020 baselines).
  • Achieved 2025 target of transitioning 100% of imported electricity to renewable sources.
  • 35% of vehicle fleet was electric or hybrid in 2025, up 7% since 2024.
  • At the end of 2025, had secured carbon credits for 8% of estimated residual emissions (i.e. 40% of carbon credit volume required to offset 20% of residual emissions in 2030).
  • Reduced overall water use in operations by 3% compared to 2024 and 30% from 2020 baseline.
  • Reduced operational waste by 18% compared to 2024, and 38% since 2020, with the amount of materials recovered by circular routes increasing 4% to 58% (compared to 2024).
  • Supplied 560 million doses of company’s vaccines and treatments to lower income countries in 2025.
  • Invested £280 million ($375 million) in communities in 2025.

Recent News

2025

GSK / WWF Launched a multi-year partnership to accelerate GSK’s nature commitments with a focus on protecting and restoring freshwater ecosystems, both within GSK’s operations and supply chain. Specifically, GSK and WWF will establish nature-based solutions in two river basins in India and Pakistan where GSK manufacturing sites and suppliers are located. The partnership aims to replenish over 300,000 cubic meters of water and positively impact over 100,000 people by 2030. (March 2025)

PR »  EDIE »



Renewable Power Program for Medicine Manufacturing — Pharmaceutical companies AstraZeneca, Takeda, and CEF member GSK have partnered along with nine suppliers to collectively procure renewable power in China.  The collaboration will unlock approximately 225 GWh of wind and solar electricity annually  for the research, development and manufacture of medicines. This builds on a 2024 agreement convened by the Sustainable Markets Initiative to access renewable power in China. (March 2025)

EDIE »


Said in its annual report that it will make changes relating to its inclusion and diversity initiatives, including no longer setting diversity targets for its leadership and supplier programs.  GSK noted that “it remained committed to operating as a responsible business with an inclusive culture,” according to reporting from Reuters. (March 2025)

REUTERS »

2024

GSK / IGNIS GSK, in partnership with Schneider Electric, announced a Virtual Power Purchase Agreement (VPPA) with renewable energy group IGNIS. This VPPA will facilitate the supply of 200 GWh of renewable electricity certificates per year. This VPPA will account for approximately 50% of GSK’s total electricity demand in Europe for 12 years, starting in mid-2026. Schneider Electric advised during the project evaluation and PPA negotiation phases. (March 2024)

PR »

2023

 Will start Phase III trials of a low emissions version of its metered dose inhaler, using a next generation propellant, in 2024. This could reduce GHG emissions from inhaler use by approximately 90%. (The current propellant accounts for 49% of GSK’s carbon footprint.) (Dec 2023)

PR »


Joined the CEF member network August 2023!


2022

GSK launched a Sustainable Procurement program that will require and support suppliers to take action on carbon, power, heat, transport, water, waste, and sustainable deforestation-free sourcing of materials. Specific areas of action include disclosing emissions; setting carbon reduction targets; switching to renewable energy; achieving water neutrality in water stressed areas; waste reductions of 10%; aligning to the company’s responsible sourcing minimum standards; and, for transport suppliers, providing green transport solutions. (Sept 2022)

MORE »


The Carbon Call — Twenty corporate, scientific, philanthropic, and intergovernmental organizations, hosted by the ClimateWorks Foundation, launched a new collaboration to accelerate the development of reliable and interoperable carbon accounting, with a focus on carbon removal and methane, indirect, and land-sector emissions. Participating organizations will work to advance universal accounting methodology standards, expand access to reliable GHG emissions and removal data, and strengthen the interoperability of digital accounting infrastructure. Corporate signatories (including CEF member Microsoft plus Capricorn Investment Group, EY, GSK, KPMG, and Wipro) commit to annually and transparently reporting on their GHG emissions and offsets, including all scopes and classes. (Feb 2022)

MORE »

2021

Lowering Emissions by Accelerating Forest finance (LEAF) Coalition — A public-private initiative to mobilize more than $1 billion to protect tropical forests from deforestation, protect the rights of local Indigenous Peoples, and support sustainable development in emerging economies. Coordinated by nonprofit Emergent, it involves the U.S., the U.K, Norway, and corporate partners Amazon, Airbnb, Bayer, Boston Consulting Group, GSK, McKinsey, Nestlé Salesforce, and Unilever. (April 2021)

MORE »